Literature DB >> 12841384

The lck promoter-driven expression of the Wilms tumor gene WT1 blocks intrathymic differentiation of T-lineage cells.

Hanfen Li1, Yoshihiro Oka, Akihiro Tsuboi, Tamotsu Yamagami, Toru Miyazaki, Sei-ichi Yusa, Kotomi Kawasaki, Yukiko Kishimoto, Momotaro Asada, Hiroko Nakajima, Keisuke Kanato, Sumiyuki Nishida, Tomoki Masuda, Masaki Murakami, Naoki Hosen, Manabu Kawakami, Hiroyasu Ogawa, Fritz Melchers, Ichiro Kawase, Yusuke Oji, Haruo Sugiyama.   

Abstract

In the thymi of WT1-transgenic (Tg) mice with the 17AA+/KTS- spliced form of the Wilms tumor gene WT1 driven by the lck promoter, the frequencies of CD4-CD8- double-negative (DN) thymocytes were significantly increased relative to those in normal littermates. Of the 4 subsets of CD4-CD8- DN thymocytes, the DN1 (CD44+CD25-) subset increased in both frequency and absolute cell number, whereas the DN2 (CD44+CD25+) and DN3 (CD44-CD25+) subsets decreased, indicating the blocking of thymocyte differentiation from the DN1 to the DN2 subsets. Furthermore, CD4-CD8+ T-cell receptor (TCR) -gammadelta T-cells increased in both frequency and absolute cell number in the spleen and peripheral blood of the WT1-Tg mice relative to those of normal littermates. The CD8 molecules of these CD4-CD8+ TCRgammadelta T-cells were CD8alphabeta, suggesting that they originated from the thymus. These results are the first direct evidence demonstrating that the WT1 gene is involved in the development and differentiation of T-lineage cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12841384     DOI: 10.1007/bf02986614

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  49 in total

1.  Very low frequencies of human normal CD34+ haematopoietic progenitor cells express the Wilms' tumour gene WT1 at levels similar to those in leukaemia cells.

Authors:  Naoki Hosen; Yoshiaki Sonoda; Yusuke Oji; Takafumi Kimura; Hitoshi Minamiguchi; Hiroya Tamaki; Manabu Kawakami; Momotaro Asada; Keisuke Kanato; Mari Motomura; Masaki Murakami; Tatsuya Fujioka; Tomoki Masuda; Eui Ho Kim; Akihiro Tsuboi; Yoshihiro Oka; Toshihiro Soma; Hiroyasu Ogawa; Haruo Sugiyama
Journal:  Br J Haematol       Date:  2002-02       Impact factor: 6.998

2.  A lymphocyte-specific protein-tyrosine kinase gene is rearranged and overexpressed in the murine T cell lymphoma LSTRA.

Authors:  J D Marth; R Peet; E G Krebs; R M Perlmutter
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

3.  High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients.

Authors:  Yasuo Miyoshi; Akiko Ando; Chiyomi Egawa; Tetsuya Taguchi; Yasuhiro Tamaki; Hiroya Tamaki; Haruo Sugiyama; Shinzaburo Noguchi
Journal:  Clin Cancer Res       Date:  2002-05       Impact factor: 12.531

4.  Cytotoxic T-lymphocyte responses elicited to Wilms' tumor gene WT1 product by DNA vaccination.

Authors:  A Tsuboi; Y Oka; H Ogawa; O A Elisseeva; H Li; K Kawasaki; K Aozasa; T Kishimoto; K Udaka; H Sugiyama
Journal:  J Clin Immunol       Date:  2000-05       Impact factor: 8.317

5.  Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells.

Authors:  K Inoue; H Tamaki; H Ogawa; Y Oka; T Soma; T Tatekawa; Y Oji; A Tsuboi; E H Kim; M Kawakami; T Akiyama; T Kishimoto; H Sugiyama
Journal:  Blood       Date:  1998-04-15       Impact factor: 22.113

6.  Kinetics of T cell receptor beta, gamma, and delta rearrangements during adult thymic development: T cell receptor rearrangements are present in CD44(+)CD25(+) Pro-T thymocytes.

Authors:  M Capone; R D Hockett; A Zlotnik
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

7.  Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers.

Authors:  Yusuke Oji; Shinichiro Miyoshi; Hajime Maeda; Seiji Hayashi; Hiroya Tamaki; Shin-Ichi Nakatsuka; Masayuki Yao; Eigo Takahashi; Yoko Nakano; Hirohisa Hirabayashi; Yasushi Shintani; Yoshihiro Oka; Akihiro Tsuboi; Naoki Hosen; Momotaro Asada; Tatsuya Fujioka; Masaki Murakami; Keisuke Kanato; Mari Motomura; Eui Ho Kim; Manabu Kawakami; Kazuhiro Ikegame; Hiroyasu Ogawa; Katsuyuki Aozasa; Ichiro Kawase; Haruo Sugiyama
Journal:  Int J Cancer       Date:  2002-07-20       Impact factor: 7.396

8.  Molecular mechanisms possibly affecting WT1 function in human ovarian tumors.

Authors:  A Viel; F Giannini; E Capozzi; V Canzonieri; C Scarabelli; A Gloghini; M Boiocchi
Journal:  Int J Cancer       Date:  1994-05-15       Impact factor: 7.396

9.  Expression of the Wilms' tumor gene (WT1) in human leukemias.

Authors:  H Miwa; M Beran; G F Saunders
Journal:  Leukemia       Date:  1992-05       Impact factor: 11.528

10.  Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth.

Authors:  Y Oji; H Ogawa; H Tamaki; Y Oka; A Tsuboi; E H Kim; T Soma; T Tatekawa; M Kawakami; M Asada; T Kishimoto; H Sugiyama
Journal:  Jpn J Cancer Res       Date:  1999-02
View more
  3 in total

1.  Prognostic implications of mutations and expression of the Wilms tumor 1 (WT1) gene in adult acute T-lymphoblastic leukemia.

Authors:  Sandra Heesch; Nicola Goekbuget; Andrea Stroux; Jutta Ortiz Tanchez; Cornelia Schlee; Thomas Burmeister; Stefan Schwartz; Olga Blau; Ulrich Keilholz; Antonia Busse; Dieter Hoelzer; Eckhard Thiel; Wolf-Karsten Hofmann; Claudia D Baldus
Journal:  Haematologica       Date:  2010-04-30       Impact factor: 9.941

2.  Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression.

Authors:  Yoshihiro Oka; Akihiro Tsuboi; Tetsuya Taguchi; Tadashi Osaki; Taiichi Kyo; Hiroko Nakajima; Olga A Elisseeva; Yusuke Oji; Manabu Kawakami; Kazuhiro Ikegame; Naoki Hosen; Satoshi Yoshihara; Fei Wu; Fumihiro Fujiki; Masaki Murakami; Tomoki Masuda; Sumiyuki Nishida; Toshiaki Shirakata; Shin-Ichi Nakatsuka; Ayako Sasaki; Keiko Udaka; Hiroo Dohy; Katsuyuki Aozasa; Shinzaburo Noguchi; Ichiro Kawase; Haruo Sugiyama
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-13       Impact factor: 11.205

3.  Evaluating Established Roles, Future Perspectives and Methodological Heterogeneity for Wilms' Tumor 1 (WT1) Antigen Detection in Adult Renal Cell Carcinoma, Using a Novel N-Terminus Targeted Antibody (Clone WT49).

Authors:  Dorin Novacescu; Talida Georgiana Cut; Alin Adrian Cumpanas; Silviu Constantin Latcu; Razvan Bardan; Ovidiu Ferician; Cosmin-Ciprian Secasan; Andrei Rusmir; Marius Raica
Journal:  Biomedicines       Date:  2022-04-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.